-A Goldin Researcher Activity Profile

Research Author Detailed Information 

A Goldin Publication Rate By Year

A Goldin has published 6 paper(s) in 1949, 1 paper(s) in 1958, 2 paper(s) in 1960, 1 paper(s) in 1961, 4 paper(s) in 1962, 1 paper(s) in 1963, 1 paper(s) in 1964, 2 paper(s) in 1965, 5 paper(s) in 1966, 1 paper(s) in 1967, 2 paper(s) in 1968, 5 paper(s) in 1970, 1 paper(s) in 1971, 6 paper(s) in 1972, 4 paper(s) in 1973, 2 paper(s) in 1974, 2 paper(s) in 1975, 1 paper(s) in 1976, 1 paper(s) in 1978, 1 paper(s) in 1979, 1 paper(s) in 1980, 2 paper(s) in 1981, 1 paper(s) in 1982, for a total of 53 research publications in total.

A A Goldin Author Information

LAST NAME: goldin

FIRST NAME: a

INITIALS: A

AFFILIATION:

Papers

A Goldin's Publication Record

1. The effect of folic-acid derivatives on sarcoma 180. Year Published: 1949
2. Cancer chemotherapy; analysis of results of different screening techniques with nitrogen-mustard analogues. Year Published: 1949
3. Reversal of aminopterin-induced inhibition of sarcoma 180 by folic acid. Year Published: 1949
4. Effectiveness of nitrogen mustards in retarding the growth of sarcoma 180 with reference to route of administration, age of tumors, food intake, and weight loss of the mice. Year Published: 1949
5. Cancer chemotherapy; analysis of results of different screening techniques with nitrogen-mustard analogues. Year Published: 1949
6. Cancer chemotherapy; analysis of results of different screening techniques with nitrogen-mustard analogues. Year Published: 1949
7. Effect of reserpine and promazine on diphosphopyridine nucleotide synthesis in liver. Year Published: 1958
8. Criteria for selection of new analogs of antitumor antibiotics. Year Published: 1978
9. Interrelationship between chemotherapy and immunotherapy in the treatment of disseminated disease. Year Published: 1979
10. The new NCI screen and its implications for clinical evaluation. Year Published: 1980
11. Chemotherapy immunogenicity. Year Published: 1981
12. A prospective screening program: current screening and its status. Year Published: 1981
13. Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. Year Published: 1982
14. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210. Year Published: 1965
15. Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Year Published: 1966
16. Experimental screening procedures and clinical predictability value. Year Published: 1966
17. Effectiveness of daunomycin (NSC-82151) against experimental tumors. Year Published: 1967
18. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma. Year Published: 1968
19. Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice. Year Published: 1968
20. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues. Year Published: 1970
21. Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L1210 with 5(or 4)-[3,3-bis( 2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196). Year Published: 1970
22. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210. Year Published: 1970
23. Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196). Year Published: 1970
24. Antileukemic action of a new sugar derivative dimethanesulfonate (NSC-122402) and related compounds in mice. Year Published: 1970
25. On screening procedures. Year Published: 1971
26. Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents. Year Published: 1972
27. The chemotherapy of human and animal acute leukemia. Year Published: 1972
28. Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151). Year Published: 1972
29. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210. Year Published: 1972
30. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210. Year Published: 1972
31. Effect of day of dosage omission on survival time in the regularly scheduled methotrexate (NSC-740) treatment of leukemia L1210. Year Published: 1972
32. A quick reference chart on cross resistance between anticancer patients. Year Published: 1973
33. Relationship between white blood cell count and diagnosis and therapeutic response in AKR mice with spontaneous leukemia (lymphoma). Year Published: 1973
34. Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA). Year Published: 1973
35. Chemotherapeutic response of epithelial tumors produced by primary implantation of a nonproducer line of murine sarcoma virus-transformed BALB 3T3 cells. Year Published: 1973
36. Evaluation of actinomycins in experimental systems. Year Published: 1974
37. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo. Year Published: 1974
38. Prevention of cyclophosphamide (NSC-26271) immunosuppression by bacillus Calmette-Guérin. Year Published: 1975
39. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems. Year Published: 1975
40. Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724). Year Published: 1976
41. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice. Year Published: 1961
42. Evaluation of surgery and chemotherapy in the treatment of mouse mammary adenocarcinoma 755. Year Published: 1962
43. A manual on quantitative drug evaluation in experimental tumor systems. Year Published: 1962
44. Effect of frozen storage on the response to therapy of drug-resistant transplantable mouse tumors. Year Published: 1962
45. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants. Year Published: 1962
46. The antileukemic effectiveness of methylglyoxal bis(guanylhydrazone) in mice. Studies of cross-resistance and combination chemotherapy. Year Published: 1963
47. THE INFLUENCE OF LEUROCRISTINE ON TRANSPLANATION IMMUNITY. Year Published: 1964
48. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES. Year Published: 1965
49. The effectiveness of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio] purine against transplantable mouse leukemia. Year Published: 1960
50. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice. Year Published: 1960
51. Effect of antitumor agents on the hematology and transplantability of leukemia L-1210. Year Published: 1966
52. Response of leukemoid reaction induced by Bordetella pertussis vaccine to chemotherapeutic agents. Year Published: 1966
53. Relationship of drug toxicity to chemotherapeutic effectiveness. Year Published: 1966